CN106770517A - A kind of method of mice skeletal myostatin content after detection exhausted movemeat - Google Patents
A kind of method of mice skeletal myostatin content after detection exhausted movemeat Download PDFInfo
- Publication number
- CN106770517A CN106770517A CN201611166543.6A CN201611166543A CN106770517A CN 106770517 A CN106770517 A CN 106770517A CN 201611166543 A CN201611166543 A CN 201611166543A CN 106770517 A CN106770517 A CN 106770517A
- Authority
- CN
- China
- Prior art keywords
- myostatin
- antibody
- particle
- gold electrode
- nano platinum
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 108010056852 Myostatin Proteins 0.000 title claims abstract description 60
- 241000699670 Mus sp. Species 0.000 title claims abstract description 24
- 238000000034 method Methods 0.000 title claims abstract description 17
- 102000004472 Myostatin Human genes 0.000 title claims abstract 20
- 238000001514 detection method Methods 0.000 title claims description 16
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 claims abstract description 66
- 239000002245 particle Substances 0.000 claims abstract description 45
- 229910052697 platinum Inorganic materials 0.000 claims abstract description 33
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims abstract description 22
- 239000010931 gold Substances 0.000 claims abstract description 22
- 229910052737 gold Inorganic materials 0.000 claims abstract description 22
- 230000000694 effects Effects 0.000 claims abstract description 14
- 229910000033 sodium borohydride Inorganic materials 0.000 claims abstract description 13
- 239000012279 sodium borohydride Substances 0.000 claims abstract description 13
- 230000004048 modification Effects 0.000 claims abstract description 11
- 238000012986 modification Methods 0.000 claims abstract description 11
- BTJIUGUIPKRLHP-UHFFFAOYSA-N 4-nitrophenol Chemical compound OC1=CC=C([N+]([O-])=O)C=C1 BTJIUGUIPKRLHP-UHFFFAOYSA-N 0.000 claims abstract description 8
- GPRSOIDYHMXAGW-UHFFFAOYSA-N cyclopenta-1,3-diene cyclopentanecarboxylic acid iron Chemical compound [CH-]1[CH-][CH-][C-]([CH-]1)C(=O)O.[CH-]1C=CC=C1.[Fe] GPRSOIDYHMXAGW-UHFFFAOYSA-N 0.000 claims abstract description 7
- 230000004044 response Effects 0.000 claims abstract description 4
- 239000012467 final product Substances 0.000 claims abstract description 3
- 238000007654 immersion Methods 0.000 claims abstract 2
- 239000000243 solution Substances 0.000 claims description 22
- 239000008055 phosphate buffer solution Substances 0.000 claims description 12
- 239000000523 sample Substances 0.000 claims description 12
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 8
- 239000002105 nanoparticle Substances 0.000 claims description 7
- 230000003647 oxidation Effects 0.000 claims description 6
- 238000007254 oxidation reaction Methods 0.000 claims description 6
- 238000002360 preparation method Methods 0.000 claims description 6
- 210000002027 skeletal muscle Anatomy 0.000 claims description 6
- 239000007788 liquid Substances 0.000 claims description 5
- 241000699666 Mus <mouse, genus> Species 0.000 claims description 4
- 229910019142 PO4 Inorganic materials 0.000 claims description 4
- 229960005070 ascorbic acid Drugs 0.000 claims description 4
- 235000010323 ascorbic acid Nutrition 0.000 claims description 4
- 239000011668 ascorbic acid Substances 0.000 claims description 4
- 238000006243 chemical reaction Methods 0.000 claims description 4
- 238000004140 cleaning Methods 0.000 claims description 4
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 4
- 229910000397 disodium phosphate Inorganic materials 0.000 claims description 4
- 239000000047 product Substances 0.000 claims description 4
- 230000007423 decrease Effects 0.000 claims description 3
- 150000002343 gold Chemical class 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 claims description 2
- 150000004062 1,4-benzoquinone imines Chemical class 0.000 claims description 2
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 claims description 2
- CDAWCLOXVUBKRW-UHFFFAOYSA-N 2-aminophenol Chemical compound NC1=CC=CC=C1O CDAWCLOXVUBKRW-UHFFFAOYSA-N 0.000 claims description 2
- IQUPABOKLQSFBK-UHFFFAOYSA-N 2-nitrophenol Chemical compound OC1=CC=CC=C1[N+]([O-])=O IQUPABOKLQSFBK-UHFFFAOYSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 238000006555 catalytic reaction Methods 0.000 claims description 2
- 150000001875 compounds Chemical class 0.000 claims description 2
- 230000009514 concussion Effects 0.000 claims description 2
- 238000002484 cyclic voltammetry Methods 0.000 claims description 2
- 238000010790 dilution Methods 0.000 claims description 2
- 239000012895 dilution Substances 0.000 claims description 2
- 238000001548 drop coating Methods 0.000 claims description 2
- 230000005518 electrochemistry Effects 0.000 claims description 2
- 239000006260 foam Substances 0.000 claims description 2
- 239000011521 glass Substances 0.000 claims description 2
- 238000010438 heat treatment Methods 0.000 claims description 2
- 230000002045 lasting effect Effects 0.000 claims description 2
- NICDRCVJGXLKSF-UHFFFAOYSA-N nitric acid;trihydrochloride Chemical compound Cl.Cl.Cl.O[N+]([O-])=O NICDRCVJGXLKSF-UHFFFAOYSA-N 0.000 claims description 2
- 239000012488 sample solution Substances 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims description 2
- 235000013399 edible fruits Nutrition 0.000 claims 1
- 235000013372 meat Nutrition 0.000 claims 1
- 238000004321 preservation Methods 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 238000003756 stirring Methods 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 abstract description 3
- 102100039939 Growth/differentiation factor 8 Human genes 0.000 description 42
- 230000005611 electricity Effects 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 238000003556 assay Methods 0.000 description 3
- 238000000835 electrochemical detection Methods 0.000 description 3
- 108050006583 Growth/differentiation factor 8 Proteins 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000002503 granulosa cell Anatomy 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 239000011943 nanocatalyst Substances 0.000 description 2
- 230000004096 skeletal muscle tissue growth Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 102100031168 CCN family member 2 Human genes 0.000 description 1
- 229910002621 H2PtCl6 Inorganic materials 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 101000777550 Homo sapiens CCN family member 2 Proteins 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 206010028289 Muscle atrophy Diseases 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 238000010531 catalytic reduction reaction Methods 0.000 description 1
- 230000004663 cell proliferation Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 238000004891 communication Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000002795 fluorescence method Methods 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 239000000893 inhibin Substances 0.000 description 1
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 1
- 238000012417 linear regression Methods 0.000 description 1
- 230000037257 muscle growth Effects 0.000 description 1
- 201000000585 muscular atrophy Diseases 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000011896 sensitive detection Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N27/00—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means
- G01N27/26—Investigating or analysing materials by the use of electric, electrochemical, or magnetic means by investigating electrochemical variables; by using electrolysis or electrophoresis
- G01N27/28—Electrolytic cell components
- G01N27/30—Electrodes, e.g. test electrodes; Half-cells
- G01N27/327—Biochemical electrodes, e.g. electrical or mechanical details for in vitro measurements
- G01N27/3275—Sensing specific biomolecules, e.g. nucleic acid strands, based on an electrode surface reaction
- G01N27/3278—Sensing specific biomolecules, e.g. nucleic acid strands, based on an electrode surface reaction involving nanosized elements, e.g. nanogaps or nanoparticles
Abstract
The invention belongs to electrochemical sensor field, its principle is that the effect of antibody and golden nanometer particle is recycled using golden nanometer particle modified electrode, prepares the gold electrode of antibody modification, obtains final product antibody/golden nanometer particle/gold electrode.Then by antibody/golden nanometer particle/gold electrode sample of the immersion containing myostatin, antibody modification nano platinum particle is added.Sandwich structure is formed using the effect of myostatin and antibody, in p-nitrophenol PNP, NaBH4, ferrocenecarboxylic acid Fc system in there is redox cycle, electrochemical response signal is amplified.Power according to electrochemical signals can realize the measure to myostatin;And mice skeletal myostatin content after exhausted movemeat is determined, method have it is simple to operate, it is with low cost, the characteristics of sensitivity is high.
Description
Technical field
The invention belongs to electrochemical sensor field, and in particular to mice skeletal muscle life after one kind detection exhausted movemeat
The method for suppressing cellulose content long.
Background technology
Myostatin (Myostatin, MSTN), is Skeletal Muscle Growth also known as Growth differentiation factor 8 (GDF-8)
The major regulator of development, it is mainly expressed in skeletal muscle, and it develops inhibited to Skeletal Muscle Growth, is in recent years
Come a kind of muscle specific albumen [Furihata T, Kinugawa S, Fukushima A, the et al.Serum for finding
myostatin levels are independently associated with skeletal muscle wasting in
patients with heart failure[J].International Journal of Cardiology,2016,22:
483-487].Myostatin content in the tissue is grown with important influence, therefore to muscle growth to flesh
The measure for suppressing cellulose content has great importance.The method that document report determines myostatin mainly has fluorescence method
[Tian Zhenjun, He Zhixiong, Liu Zhiwei wait persistently and interval aerobic exercise are to heart infarction rat heart muscle Myostatin and its by body surface
Influence [J] the sports sciences for reaching, 2013,33 (11):66-74.], chemoluminescence method [Chang H M, Fang L, Cheng J
C,et al.Growth differentiation factor 8down-regulates pentraxin 3in human
granulosa cells[J].Molecular&Cellular Endocrinology,2015,404:82-90.Chang H M,
Pan H H,Cheng J C,et al.Growth differentiation factor 8suppresses cell
proliferation by up-regulating CTGF expression in human granulosa cells.[J]
.Molecular&Cellular Endocrinology,2016,422:9-17.].In recent years, urged based on electrochemical redox
Changing reaction assay new method becomes one of focus [Das J, Aziz M A, Yang H.A nanocatalyst-based
assay for proteins:DNA-free ultrasensitive electrochemical detection using
catalytic reduction of p-nitrophenol by gold-nanoparticle labels.[J].Journal
of the American Chemical Society,2006,128(128):16022-16023.Hun X,Xie G,Luo
X.Scaling up an electrochemical signal with a catalytic hairpin assembly
coupling nanocatalyst label for DNA detection.[J].Chemical Communications,
2015,51(33):7100-7103].In order to further improve the sensitivity to MSTN detections, nano platinum particle labelled antibody is used,
With the catalytic amplification of nano platinum particle, a kind of electrochemistry new method of highly sensitive detection myostatin is constructed,
And for the measure of mice skeletal myostatin content after exhausted movemeat.
The content of the invention
It is contemplated that it is simple to operate to invent a kind of method, with low cost, sensitivity measure myostatin high
Method.
Realizing goal of the invention technical scheme is:
A kind of method of mice skeletal myostatin content after detection exhausted movemeat.Its principle is to utilize Jenner
Rice corpuscles modified electrode, recycles the effect of antibody and golden nanometer particle, prepares the gold electrode of antibody modification, obtains final product antibody/gold
Nano-particle/gold electrode.Then antibody/golden nanometer particle/gold electrode is immersed in the sample containing myostatin, then
Add antibody modification nano platinum particle.Sandwich structure is formed using the effect of myostatin and antibody, right
Nitrophenol PNP, NaBH4, ferrocenecarboxylic acid Fc system in, nano platinum particle is in NaBH4It is right that the lower catalysis PNP of effect is converted into
Amino-phenol PAP, the PAP of generation is by the Fc oxidations in solution, oxidation product 1,4-benzoquinone imines p-quinone imine and quilt
NaBH4PAP is reduced into, lasting redox is produced between such PAP and oxidation product, so that electrochemical signals are produced,
There is redox cycle in the presence of nano platinum particle, electrochemical response signal is amplified.According to the strong of electrochemical signals
The weak measure that can be realized to myostatin;And mice skeletal myostatin content after exhausted movemeat is entered
Measure is gone.
Determination step is:
(1) preparation of nano platinum particle
First, the glass apparatus chloroazotic acid foam washing used by nano platinum particle, dry for standby will be prepared.Then by the dense of 7mL
The ascorbic acid for adding that 1.0mL concentration is 1% is spent in the platinum acid chloride solution for 1%, under the conditions of 80 DEG C, is stirred 20 minutes, when molten
Liquid becomes dark brown and stops heating, obtains nano platinum particle, is cooled to room temperature, is saved backup under the conditions of 4 DEG C.
(2) preparation of antibody modification nano platinum particle
First, the 2mL nano platinum particles solution for preparing is mixed with the phosphate buffer solution of 8mL pH 7.4, is diluted
Nano platinum particle, nano platinum particle 2mL and 0.5mL the myostatin antibody for then pipetting dilution mixes, 37 DEG C of bars
Under part, concussion reaction 24h obtains antibody/nano platinum particle compound, using supercentrifuge eccentric cleaning after, be dispersed again in
In PBS cushioning liquid, preserved at 4 DEG C.
(3) preparation of antibody modification gold electrode
First, the solution of gold nanoparticles of 10 μ L is added dropwise in the gold electrode surfaces handled well, 10h is incubated under the conditions of 4 DEG C,
Obtain golden nanometer particle modified gold electrode.Then by the myostatin antibody drop coating of 10 μ L in golden nanometer particle modification gold electricity
Pole surface, under the conditions of 37 DEG C, react 24h, obtain antibody/golden nanometer particle/gold electrode, with phosphate buffer solution cleaning electrode after,
Preserved at 4 DEG C.
(4) detection of myostatin
Antibody/golden nanometer particle/gold electrode is immersed in the sample solution containing myostatin, under the conditions of 37 DEG C
Reaction 2h, then electrode is taken out, flushed three times with phosphate buffer solution, be inserted into pH 7.4 PNP containing 5mmol/L,
5mmol/L NaBH4In the phosphate buffer solution of 5mmol/L Fc, on electrochemical workstation, electricity is detected with cyclic voltammetry
Chemical signal, current potential is -200~600mV (vs.SCE), uses 50mV s-1Velocity scanning.
(5) mice skeletal myostatin content detection after exhausted movemeat
Exhausted movemeat is carried out to mouse and is drawn materials, mice skeletal myostatin contains after detection exhausted movemeat
Amount, as a result shows, the content of mice skeletal myostatin is 4.56ng/mg, control group mice bone after exhausted movemeat
The content of bone flesh myostatin is 5.72ng/mg;Show, mice skeletal myostatin after exhausted movemeat
Content decreases compared with control group.
Described myostatin, myostatin antibody are purchased from R&D Systems companies.
Described chloroplatinic acid (H2PtCl6), ascorbic acid, ferrocenecarboxylic acid (Fc) purchased from Chinese medicines group chemical reagent it is limited
Company.
Described sodium borohydride (NaBH4), p-nitrophenol (PNP) be purchased from Tianjin chemical reagent Co., Ltd.
The water used in experimentation is redistilled water.
By the KH of 21mL 0.2mol/L2PO4, 78mL 0.2mol/L Na2HPO4·12H2O mixes, and adds KCl to consolidate
Body so that the concentration of KCl is 0.1mol/L, obtains the PBS cushioning liquid that 0.1mol/L pH are 7.4.
Described phosphate buffer solution collocation method is:By the KH of 21mL 0.2mol/L2PO4, 78mL 0.2mol/L
Na2HPO4·12H2O mixes, and obtains the phosphate buffer solution that 0.1mol/L pH are 7.4;
Electrochemical Detection uses CHI760E electrochemical workstations (Shanghai Chen Hua instrument company).
Z300K supercentrifuges (Hermle, Germany) are used for centrifugation.
Brief description of the drawings
Fig. 1 detects the principle schematic of myostatin content.
Fig. 2 antibody/nano platinum particle solution usage (A) and probe solution and sample effect time (B) are to electrochemical signals
The influence of intensity.
Fig. 3 myostatins concentration and electrochemical signals graph of a relation.
The advantage and effect of invention
Under optimal testing conditions, the standard curve of myostatin is obtained detecting, the range of linearity and linear
Equation.When the concentration of myostatin concentration is between 0.7~25.0ng/mL, the signal intensity of system is with muscle life
The increase of inhibin concentration long and increase.The equation of linear regression for obtaining myostatin is ip=0.6536C+15.584
(ipIt is the signal intensity of system;C is the concentration of myostatin, 10-8ng/mL;N=7, R=0.999) (such as Fig. 3 institutes
Show).The method detection is limited to 0.3ng/mL (3 σ).Myostatin to concentration 3.0ng/mL carries out 7 parallel repetitions
The RSD of measure is 4.3%, shows that this law has preferable reappearance.
Specific embodiment
The present invention is further illustrated with reference to specific embodiment, but does not constitute the further limitation to inventing.
1 antibody of embodiment/influence of the nano platinum particle solution usage to electrochemical signals
Fixed probe solution and sample effect time, antibody/nano platinum particle solution usage has been investigated to Electrochemical Detection
The influence of signal.Result shows, when antibody/nano platinum particle solution usage solution usage from 20 μ of μ L to 120 L when increasing, electricity
Chemical signal strengthens with the increase of volume;When consumption is more than 90 μ L, electrochemical signals increase slows down (as shown in Figure 2 A).Cause
This, it is the optimum amount of antibody/nano platinum particle solution that 90 μ L are chosen in experiment.
The influence of the probe solution of embodiment 2 and sample effect time to electrochemical response signal
When sessile antibody/nano platinum particle solution usage is 90 μ L, probe solution and sample effect time electricity have been investigated
Influence of the chemistry to signal intensity, with the increase of action time, electrochemical signals gradually strengthen, and are 30min when action time
When, electrochemical signals maximum (as shown in Figure 2 B).Therefore, experiment chooses 30min as probe solution and sample effect time
Optimum amount.
Mice skeletal myostatin content detection after the exhausted movemeat of embodiment 3
Exhausted movemeat is carried out to mouse and is drawn materials, mice skeletal myostatin contains after detection exhausted movemeat
Amount, testing result is as shown in table 1.Result shows that the content of mice skeletal myostatin is after exhausted movemeat
4.56ng/mg, the content of control group mice skeletal muscle myostatin is 5.72ng/mg.Show, mouse after exhausted movemeat
The content of skeletal muscle myostatin decreases compared with control group.
The assay result of mice skeletal myostatin after the exhausted movemeat of table 1.
aN=7;C is control group;S exhausted movemeat groups.
Claims (2)
1. it is a kind of detect exhausted movemeat after mice skeletal myostatin content method, it is characterised in that utilize Jenner
Rice corpuscles modified electrode, recycles the effect of antibody and golden nanometer particle, prepares the gold electrode of antibody modification, obtains final product antibody/gold
Nano-particle/gold electrode;Then antibody/golden nanometer particle/gold electrode is immersed in the sample containing myostatin, then
Add antibody modification nano platinum particle;Sandwich structure is formed using the effect of myostatin and antibody, right
Nitrophenol PNP, NaBH4, ferrocenecarboxylic acid Fc system in, nano platinum particle is in NaBH4It is right that the lower catalysis PNP of effect is converted into
Amino-phenol PAP, the PAP of generation is by the Fc oxidations in solution, oxidation product 1,4-benzoquinone imines p-quinone imine and quilt
NaBH4PAP is reduced into, lasting redox is produced between such PAP and oxidation product, so that electrochemical signals are produced,
There is redox cycle in the presence of nano platinum particle, electrochemical response signal is amplified;According to the strong of electrochemical signals
The weak measure that can be realized to myostatin;Determination step is as follows:
(1) preparation of nano platinum particle
First, the glass apparatus chloroazotic acid foam washing used by nano platinum particle, dry for standby will be prepared;Then it is 1% by 7mL concentration
Platinum acid chloride solution in add 1.0mL concentration be 1% ascorbic acid, under the conditions of 80 DEG C, stir 20 minutes, when solution becomes black
Brown stops heating, obtains nano platinum particle, is cooled to room temperature, is saved backup under the conditions of 4 DEG C;
(2) preparation of antibody modification nano platinum particle
First, the 2mL nano platinum particles solution for preparing is mixed with the phosphate buffer solution of 8mL pH 7.4, the platinum for being diluted
Nano-particle, nano platinum particle 2mL and 0.5mL the myostatin antibody for then pipetting dilution mixes, under the conditions of 37 DEG C,
Concussion reaction 24h, obtains antibody/nano platinum particle compound, using supercentrifuge eccentric cleaning after, be dispersed again in PBS delay
Rush in solution, preserved at 4 DEG C;
(3) preparation of antibody modification gold electrode
First, the solution of gold nanoparticles of 10 μ L is added dropwise in the gold electrode surfaces handled well, 10h is incubated under the conditions of 4 DEG C, obtain golden
Nanoparticle Modified gold electrode;Then by the myostatin antibody drop coating of 10 μ L in golden nanometer particle modified gold electrode table
Face, under the conditions of 37 DEG C, react 24h, obtain antibody/golden nanometer particle/gold electrode, with phosphate buffer solution cleaning electrode after, at 4 DEG C
Lower preservation;
(4) detection of myostatin
By in antibody/golden nanometer particle/gold electrode sample solution of the immersion containing myostatin, reacted under the conditions of 37 DEG C
2h, then takes out electrode, is flushed three times with phosphate buffer solution, is inserted into PNP containing 5mmol/L, the 5mmol/L of pH 7.4
NaBH4In the phosphate buffer solution of 5mmol/L Fc, on electrochemical workstation, believed with cyclic voltammetry detection electrochemistry
Number, current potential is -200~600mV, uses 50mV s-1Velocity scanning;
(5) mice skeletal myostatin content detection after exhausted movemeat
Exhausted movemeat is carried out to mouse and is drawn materials, the content of mice skeletal myostatin, knot after detection exhausted movemeat
Fruit shows that the content of mice skeletal myostatin is 4.56ng/mg, control group mice Skeletal Muscle after exhausted movemeat
The content of meat amicine is 5.72ng/mg;Show, after exhausted movemeat the content of mice skeletal myostatin compared with
Control group decreases.
2. it is according to claim 1 it is a kind of detect exhausted movemeat after mice skeletal myostatin content method, its
Myostatin, myostatin antibody described in being characterised by are purchased from R&D Systems companies;
Described chloroplatinic acid, ascorbic acid, ferrocenecarboxylic acid is purchased from Chemical Reagent Co., Ltd., Sinopharm Group;
Described sodium borohydride NaBH4, p-nitrophenol PNP be purchased from Tianjin chemical reagent Co., Ltd;
Described PBS cushioning liquid collocation methods are:By the KH of 21mL 0.2mol/L2PO4, 78mL 0.2mol/L
Na2HPO4·12H2O mixes, and adds KCl solids so that the concentration of KCl is 0.1mol/L, and it is 7.4 to obtain 0.1mol/LpH
PBS cushioning liquid;
Described phosphate buffer solution collocation method is:By the KH of 21mL 0.2mol/L2PO4, 78mL 0.2mol/L
Na2HPO4·12H2O mixes, and obtains the phosphate buffer solution that 0.1mol/L pH are 7.4;
Described electrochemical workstation is the CHI760E electrochemical workstations of Shanghai Chen Hua instrument company;
Described supercentrifuge is Z300K supercentrifuges.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611166543.6A CN106770517A (en) | 2016-12-16 | 2016-12-16 | A kind of method of mice skeletal myostatin content after detection exhausted movemeat |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201611166543.6A CN106770517A (en) | 2016-12-16 | 2016-12-16 | A kind of method of mice skeletal myostatin content after detection exhausted movemeat |
Publications (1)
Publication Number | Publication Date |
---|---|
CN106770517A true CN106770517A (en) | 2017-05-31 |
Family
ID=58893003
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201611166543.6A Pending CN106770517A (en) | 2016-12-16 | 2016-12-16 | A kind of method of mice skeletal myostatin content after detection exhausted movemeat |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106770517A (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102933602A (en) * | 2010-05-26 | 2013-02-13 | 瑞泽恩制药公司 | Antibodies to human GDF8 |
CN104007152A (en) * | 2014-06-18 | 2014-08-27 | 青岛科技大学 | DNA determining electrochemical sensor and method based on platinum nano particle catalysis electrochemistry circulation signal amplification technology |
-
2016
- 2016-12-16 CN CN201611166543.6A patent/CN106770517A/en active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102933602A (en) * | 2010-05-26 | 2013-02-13 | 瑞泽恩制药公司 | Antibodies to human GDF8 |
CN104007152A (en) * | 2014-06-18 | 2014-08-27 | 青岛科技大学 | DNA determining electrochemical sensor and method based on platinum nano particle catalysis electrochemistry circulation signal amplification technology |
Non-Patent Citations (4)
Title |
---|
PATRICK DIEL等: "Analysis of the effects of androgens and training on myostatin propeptide and follistatin concentrations in blood and skeletal muscle using highly sensitive Immuno PCR", 《MOLECULAR AND CELLULAR ENDOCRINOLOGY》 * |
ZHAO-PENG CHEN等: "A sensitive immunosensor using colloidal gold as electrochemical label", 《TALANTA》 * |
平靖: "电化学核酸适配体传感器及在环境监测方面的应用", 《化学世界》 * |
谢国亮: "基于纳米粒子标记催化氧化还原循环信号放大技术的构建及其应用研究", 《中国优秀硕士学位论文全文数据库工程科技Ⅰ辑》 * |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN107345931B (en) | It is a kind of based on carbonitride-binary metal boron oxide compound composite material bisphenol-A optical electro-chemistry sensor and its preparation and application | |
CN107202828B (en) | A kind of estradiol optical electro-chemistry sensor and its preparation and application based on boron doping iron cobalt/cobalt oxide two-dimensional nano composite material | |
CN106248748B (en) | A kind of acetylcholinesterasebiosensor biosensor and its application | |
Li et al. | A strategy for constructing sensitive and renewable molecularly imprinted electrochemical sensors for melamine detection | |
CN108645903A (en) | The preparation and application of molecular engram sensor based on the chitosan-modified glass-carbon electrode of carbon dots- | |
CN108455652B (en) | A kind of preparation method and application of the Kocide SD nanometer rods of peroxidase | |
CN105445346B (en) | A kind of construction method of optical electro-chemistry aptamer sensor based on gold/zinc oxide composite and the detection method to bisphenol-A | |
CN104926844B (en) | Cup [8] areneboronic acid derivative and preparation, the composite containing the derivative and application | |
CN108344788A (en) | A kind of preparation method and application of the electrochemica biological sensor based on gold nanometer cage | |
CN101915792A (en) | Preparation method of electrochemical immunosensor for detecting salbutamol quickly | |
CN106525943A (en) | Construction method and application of surface protein-embossed self-energized biological fuel cell sensor | |
CN107607597A (en) | A kind of method of persimmon tannin graphene Pt composites modification screen printing electrode detection hydrogen peroxide | |
CN103196966A (en) | Hydrogen peroxide sensor, preparation method thereof, and application thereof in detecting unicellular hydrogen peroxide | |
CN108709996B (en) | Preparation method and application of gold-palladium composite nanoenzyme immunosensor | |
CN105606684B (en) | A kind of graphene based on protein-single-walled carbon nanotube-nano-Au composite preparation method and applications | |
CN102147389B (en) | Method for testing hydrogen peroxide in cell based on horseradish peroxidase-attapulgite nanometer composite material | |
CN109085225A (en) | A kind of preparation method of the protein electrochemistry trace sensor of step sedimentation modification carbon electrode | |
Naik et al. | Surfactant induced iron (II) phthalocyanine modified carbon paste electrode for simultaneous detection of ascorbic acid, dopamine and uric acid | |
CN114058025B (en) | Preparation method and application of copper simple substance/copper-based metal organic framework material | |
CN107727720A (en) | HKUST‑1(Cu‑MOFs)Application in glucose sensor electrode is prepared | |
CN110441380A (en) | A kind of electrochemical sensor and its preparation method and application based on molecular engram electrode technology | |
Zhang et al. | Electrochemical sensor for sensitive nitrite and sulfite detection in milk based on acid-treated Fe3O4@ SiO2 nanoparticles | |
CN109580731A (en) | The preparation method and the application in detection Polychlorinated biphenyls of DNA micro-capsule and gold electrode-DNA dendritic macromole sensor | |
CN109115851A (en) | A kind of preparation method and purposes of the optical electro-chemistry aptamer sensor detecting bisphenol-A | |
CN108760861A (en) | A kind of Ni-MOF based electrochemical sensors for detecting uric acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20170531 |
|
WD01 | Invention patent application deemed withdrawn after publication |